of the University of New Mexico, Albuquerque; and Fairbanks Wildlife Research Center.
The institute is interested in further collaboration in investigating Arctic wildlife.
INSTITUTE OF BIOPHYSICS, IBP (KRASNOYARSK)
In collaboration with the University of North Carolina, IBP developed new nanodiamonds-based materials for medical diagnostics and therapy. Joint projects of the institute and Luminos LLC (Ann Arbor) aimed at development of new bioluminescent probes were supported through CRDF. ISTC supported development of technology of microbial production of the biodegradable polymer Bioplastotan (hydroxybutyrate-hydroxyvalerate copolymer).
The institute is interested in collaboration for further development and production of Bioplastotan-based materials and tools for medicine.
INSTITUTE OF CYTOLOGY AND GENETICS, ICG (NOVOSIBIRSK)
This institute has collaborated with the University of California, Irvine, and the Kavli Institute of Theoretical Physics, Santa Barbara. The National Science Foundation (NSF) has supported bioinformatics research aimed at developing computer-assisted methods for interpretation of biological data and accumulation and systematization of data on gene expression in Arabidopsis. Using original animal models, ICG researchers have performed genetic studies aimed at elucidation of mechanisms of social behavior. This project was developed in collaboration with the University of Utah and supported by the National Institutes of Health (NIH). The institute collaborated with Cornell University’s James Baker Institute for Animal Health on investigations of genes responsible for formation of skeletal tissue in mammals. Further collaboration with Georgia State University focused on investigation of human genetic predisposition to severe forms of tick-borne encephalitis. ISTC supported research at Vector aimed at development of oral vaccines against hepatitis B virus, and ICG contributed to this effort.
The institute is interested in further collaboration in several fields: (a) investigation of mechanisms of metastatic tumor growth and development of therapeutics for prevention of metastasis process; (b) computer reconstruction of gene nets describing interaction of viral and bacterial pathogens with mammalian cells; (c) investigation of molecular mechanisms and identification of genes providing resistance of wheat to fungi; (d) identification of molecular targets of different nanoparticles and investigation of molecular, cellular, and physiological mechanisms of response to different nanoparticles; (e) development of micro- and nano-fluidic systems for biotechnology and medical diagnostics; and (f) investigation of mechanisms providing reprogramming of somatic cells.